e-learning
resources
Barcelona 2013
Monday, 09.09.2013
The best posters in exercise testing and physical inactivity
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Profile of systemic oxidative stress markers and effect on skeletal muscle function in COPD
J. Maury, F. Gouzi, P. De Rigal, J. Pincemail, P. Pomies, C. Prefaut, M. Hayot (Montpellier, Osséja, France; Liège, Belgium)
Source:
Annual Congress 2013 –The best posters in exercise testing and physical inactivity
Session:
The best posters in exercise testing and physical inactivity
Session type:
Poster Discussion
Number:
1844
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Maury, F. Gouzi, P. De Rigal, J. Pincemail, P. Pomies, C. Prefaut, M. Hayot (Montpellier, Osséja, France; Liège, Belgium). Profile of systemic oxidative stress markers and effect on skeletal muscle function in COPD. Eur Respir J 2013; 42: Suppl. 57, 1844
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Middle-long term pulmonary abnormalities after severe COVID-19 pneumonia which required invasive ventilation
Related content which might interest you:
Evaluation of the role of inflammation in chronic airways disease (ERICA): Midpoint evaluation
Source: Annual Congress 2013 –Diagnosis and management of respiratory diseases
Year: 2013
Markers of ageing in the limb muscle of patients with COPD
Source: International Congress 2015 – Translational research in respiratory care: new findings
Year: 2015
Does oxidative stress modulate limb muscle atrophy in severe COPD patients?},
Source: Eur Respir J 2012; 40: 851-862
Year: 2012
Systemic inflammation and exercise tolerance in COPD
Source: Annual Congress 2013 –Mechanisms contributing to exercise limitation in health and respiratory, cardiac and pulmonary vascular diseases
Year: 2013
Cachexia in patients with acute COPD exacerbations: relationship to pulmonary function, systemic inflammation and oxidative stress
Source: Annual Congress 2008 - Comorbidities in COPD
Year: 2008
From muscle disuse to myopathy in COPD: potential contribution of oxidative stress
Source: Eur Respir J 2005; 26: 703-719
Year: 2005
Does systemic inflammation trigger local exercise-induced oxidative stress in COPD?
Source: Eur Respir J 2004; 23: 538-544
Year: 2004
Oxidative stress and systemic inflammation in different COPD phenotypes
Source: International Congress 2014 – Monitoring COPD with different biomarkers
Year: 2014
A functional imaging study to investigate the relationship between pulmonary inflammation and systemic inflammation in COPD patients
Source: International Congress 2016 – From microimaging to functional evaluation of the lung
Year: 2016
Effect of oxidative stress on mitochondrial function in airway smooth muscle (ASM) cells from COPD patients
Source: Annual Congress 2013 –Airway smooth muscle and cell biology
Year: 2013
Increased oxidative stress in patients with chronic obstructive pulmonary disease (COPD) and metabolic syndrome (MetS)
Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench
Year: 2013
Systemic inflammation is associated with mitophagy signalling in skeletal muscle of COPD patients
Source: International Congress 2018 – Functional genomics and COPD: new challenges
Year: 2018
ERICA (
e
valuating the
r
ole of
i
nflammation in
c
hronic
a
irways disease): Extrapulmonary manifestations of COPD
Source: Annual Congress 2013 –The best abstracts in extra-pulmonary features and pulmonary rehabilitation
Year: 2013
Handgrip strength reflects excersice capacity and systemic inflammation in patients with chronic obstructive pulmonary disease
Source: International Congress 2016 – Systemic biomarkers
Year: 2016
Metabolomics profiling identifies female-selective upregulation of oxidative stress in individuals with COPD
Source: International Congress 2016 – Molecular targets in pulmonary disease
Year: 2016
The influence of hyperinflation on body composition and cytokine profile in patients with COPD
Source: Annual Congress 2013 –Monitoring lung function in airway diseases
Year: 2013
Cytotoxic activity and oxidative DNA damage in smoking asthmatics versus COPD patients
Source: International Congress 2015 – Inflammation and remodelling in lung disease
Year: 2015
Inhaled beta-agonist does not modify sympathetic activity in patients with COPD
Source: International Congress 2014 – Multidimensional analysis of respiratory problems
Year: 2014
Influence of reduced airway patency and respiratory muscle strength on autonomic cardiac modulation in COPD patients
Source: International Congress 2016 – Quality and quantity in lung function
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept